Details for New Drug Application (NDA): 209411
✉ Email this page to a colleague
NDA 209411 describes CLOBETASOL PROPIONATE (EMOLLIENT), which is a drug marketed by Ani Pharms, Beach Prods, Fougera Pharms, and Taro, and is included in four NDAs. It is available from three suppliers. Additional details are available on the CLOBETASOL PROPIONATE (EMOLLIENT) profile page.
The generic ingredient in CLOBETASOL PROPIONATE (EMOLLIENT) is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
The generic ingredient in CLOBETASOL PROPIONATE (EMOLLIENT) is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 209411
| Tradename: | CLOBETASOL PROPIONATE (EMOLLIENT) |
| Applicant: | Beach Prods |
| Ingredient: | clobetasol propionate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 209411
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.05% | ||||
| Approval Date: | Aug 21, 2017 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
